The most commonly reported TEAEs considered probably related to treatment with the 23-mg/d dose were nausea ( 59 patients [ 6.1 % ] vs 9 [ 1.9 % ] with the 10-mg/d dose ) , vomiting ( 48 [ 5.0 % ] vs 4 [ 0.8 % ] ) , and diarrhea ( 31 [ 3.2 % ] vs 7 [ 1.5 % ] ) .
